Nomegestrol

Nomegestrol: Overview

Nomegestrol belongs to the class of organic compounds known as gluco/mineralocorticoids, progestogins, and derivatives. Chemically, it is a 19-norprogesterone derivative (specifically a pregnadien derivative) designed to closely resemble natural human progesterone in its physiological activity.

In clinical gynecology, nomegestrol functions as a highly potent and selective progestin. It is typically formulated as an ester, nomegestrol acetate. It is widely authorized by the European Medicines Agency (EMA) and utilized across Europe and international markets most notably in combined oral contraceptives paired with 17-beta-estradiol (under the brand name Zoely) and as monotherapy or sequential hormone replacement therapy (HRT) for menopausal disorders (under brand names such as Lutenyl). It provides strong endometrial protection and anti-gonadotropic activity without intrinsic androgenic, estrogenic, or glucocorticoid side effects.

Key Facts Summary:

Nomegestrol: What Is It & How Does It Work?

Nomegestrol acts as a pure progesterone receptor agonist with high selectivity for the progesterone receptor, exerting strong anti-gonadotropic and anti-estrogenic actions on target tissues:

• Progesterone Receptor Agonism: Nomegestrol binds directly and with high affinity to progesterone receptors in target organs. It induces a full secretory transformation of the endometrium, counteracting estrogen-induced endometrial proliferation and stabilizing the uterine lining.
• Gonadotropin Inhibition (Ovulation Suppression): Through negative feedback action on the hypothalamic-pituitary-ovarian axis, it suppresses the secretion of luteinizing hormone (LH) and follicle-stimulating hormone (FSH). This prevents the mid-cycle LH surge, effectively inhibiting ovulation when used in contraceptive regimens.
• Targeted Selectivity Profile: Unlike older synthetic progestins derived from testosterone, nomegestrol lacks significant binding affinity for androgen, glucocorticoid, or mineralocorticoid receptors. This selectivity means it does not cause androgenic side effects (such as acne or hair growth) or mineralocorticoid-related fluid retention.

Nomegestrol: FDA Approval & Uses

Understanding the regulatory status of nomegestrol clarifies its clinical scope in contraception and gynecological management.

Global Regulatory Status

No. Nomegestrol is Not Approved by the US Food and Drug Administration (FDA) for commercial distribution in the United States. However, it is an approved, widely prescribed medication throughout Europe, Australia, and parts of Asia and Latin America.

Primary Indications

Where approved internationally, nomegestrol (primarily as nomegestrol acetate) is indicated for the following gynecological uses:

• Oral Contraception: Combined with 17-beta-estradiol (Zoely) as a daily monophasic oral contraceptive to prevent pregnancy in women of childbearing potential.
• Menopausal Hormone Therapy: Used as monotherapy or in sequential regimens with estrogen (Lutenyl) to treat menopausal symptoms and protect the endometrium against estrogen-induced hyperplasia.
• Menstrual Disorders: Used to manage functional gynecological disorders, including menorrhagia (heavy menstrual bleeding), secondary amenorrhea, dysmenorrhea, and premenstrual syndrome.

Before Taking Nomegestrol: Contraindications & Precautions

Before starting treatment with or taking nomegestrol, patients must review key safety precautions and underlying health risks with their healthcare provider.

Who Should Not Take Nomegestrol?

• Women with active or past venous thromboembolism (VTE), including deep vein thrombosis (DVT) or pulmonary embolism.
• Individuals with active or historical arterial thromboembolic disease (such as myocardial infarction or stroke).
• Patients with known, suspected, or past history of sex-steroid-dependent malignancies (e.g., breast cancer or endometrial cancer).
• Women with severe hepatic disease, active liver tumors, or undiagnosed abnormal vaginal bleeding.
• Patients with a history of meningioma (a risk specifically monitored with high-dose progestins).

Nomegestrol: Pregnancy & Breastfeeding

Nomegestrol is strictly contraindicated during pregnancy. If pregnancy occurs while taking nomegestrol for contraception, the medication must be discontinued immediately. Nomegestrol is excreted in small amounts in human milk and can reduce milk yield; therefore, its use is generally not recommended during breastfeeding.

Tell Your Doctor Before Taking Nomegestrol

Inform your healthcare provider if you have a history of hypertension, hyperlipidemia, diabetes mellitus, severe depression, chloasma, or a family history of blood clotting disorders before initiating therapy.

Nomegestrol: Dosage & Administration

Because nomegestrol is used across oral contraceptive and menopausal hormone therapy indications, dosing relies on specific cyclic oral schedules.

Standard Nomegestrol Dosing

• Contraceptive Regimen (Zoely): Administered as a 28-day cyclic regimen consisting of 24 active tablets (each containing 2.5 mg nomegestrol acetate and 1.5 mg estradiol) followed by 4 inactive placebo tablets taken daily.
• Gynecology / HRT Regimen (Lutenyl): Typically administered as 5 mg daily for 10 to 14 days per cycle (usually from day 14 to day 25) in perimenopausal women.

How Nomegestrol Is Administered

• Dosage Forms: Supplied internationally as oral Tablets (film-coated).
• Administration Routes: Administered strictly via the Oral route, taken once daily with water at approximately the same time each day.

Nomegestrol: Clinical Efficacy & Research

Clinical trials and extensive international gynecological studies establish the high selective progestational efficacy of nomegestrol. Research highlights its capacity to achieve reliable ovulation suppression and endometrial protection while exerting minimal impact on lipid metabolism or carbohydrate tolerance.

Trial Findings and Efficacy

International clinical trials demonstrate that nomegestrol acetate combined with 17-beta-estradiol offers high contraceptive efficacy (Pearl Index comparable to established low-dose combined pills) while providing a favorable bleeding profile characterized by short, light withdrawal bleeds or amenorrhea. Pharmacological studies confirm its clean selectivity profile, showing minimal impact on lipid metabolism, carbohydrate tolerance, or blood pressure, making it a well-tolerated option in modern contraception and hormone therapy.

Nomegestrol: Side Effects & Safety Profile

Understanding the side effect profile of nomegestrol helps clinical teams and patients monitor for adverse reactions. The safety considerations for nomegestrol are consistent with modern selective progestational agents. Because of its high receptor selectivity, it provides favorable systemic tolerance, though serious vascular and tissue risks must be monitored during therapy.

Common Nomegestrol Side Effects

• Acne or weight fluctuations (infrequent due to low intrinsic androgenicity).
• Breakthrough bleeding, spotting, or amenorrhea.
• Headache or migraine.
• Nausea and abdominal discomfort.
• Breast tenderness or pelvic pain.

Serious Nomegestrol Adverse Events

• Venous Thromboembolism: Risk of developing deep vein thrombosis (DVT) or pulmonary embolism, particularly when co-formulated with estrogens.
• Meningioma: Heightened risk of meningioma growth linked to long-term high-dose therapy, requiring immediate discontinuation if diagnosed.
• Arterial Thromboembolism: Rare instances of ischemic stroke or myocardial infarction in women with pre-existing cardiovascular risk factors.

Managing Nomegestrol Side Effects

Irregular bleeding or spotting is common during the first few months of contraceptive use and typically settles over time. If signs of a blood clot (severe leg pain, sudden shortness of breath, chest pain) or neurological symptoms occur, discontinue the medication and seek emergency medical evaluation immediately.

Nomegestrol: Drug Interactions & What to Avoid

Nomegestrol is metabolized primarily by hepatic CYP3A4 pathways, interacting with enzymatic inducers and inhibitors.

Key Nomegestrol Interactions

• CYP3A4 Inducers: Anticonvulsants (carbamazepine, phenytoin, topiramate), anti-infectives (rifampin), and herbal remedies (St. John’s Wort) enhance hepatic metabolism, leading to reduced systemic levels of nomegestrol, potential loss of contraceptive efficacy, and breakthrough bleeding.
• CYP3A4 Inhibitors: Strong inhibitors like ketoconazole, itraconazole, or erythromycin can increase systemic exposure to nomegestrol, increasing the likelihood of side effects.

Nomegestrol: Food & Alcohol

Food does not significantly alter the bioavailability of oral nomegestrol. Smoking cigarettes while taking combined hormonal contraceptives exponentially increases the risk of severe cardiovascular events and blood clots.

Nomegestrol: Missed Dose, Overdose & Storage

Proper handling, adherence, and storage protocols govern daily oral progestin management.

Missed Dose of Nomegestrol

For contraceptive regimens (Zoely):

• If a missed active tablet is delayed by less than 24 hours, take it immediately; contraceptive protection is maintained.
• If delayed by more than 24 hours, take the missed tablet immediately (even if it means taking two tablets at once) and follow standard back-up rules (using condoms for 7 days if required by the week of the cycle).

Nomegestrol: Overdose

An acute overdose is non-life-threatening. Overdosage may cause nausea, vomiting, and, in young females, mild withdrawal bleeding. Treatment is supportive and symptomatic.

How to Store Nomegestrol

Store tablets at controlled room temperature (15°C to 30°C or 59°F to 77°F), protected from light and moisture. Keep safely out of reach of children.

Nomegestrol: Patient Management & Guidelines

Effective clinical management relies on routine baseline medical examinations, blood pressure tracking, and clinical vigilance for meningioma symptoms.

Tests Before & During Nomegestrol Treatment

• Baseline Exams: A comprehensive personal and family medical history, blood pressure check, and pelvic exam before starting treatment.
• Cardiovascular & Blood Pressure Checks: Routine blood pressure monitoring during follow-up visits.
• Meningioma Screening: For patients on high-dose long-term regimens, clinical vigilance for neurological symptoms (e.g., vision changes, persistent headaches).

Nomegestrol: Do’s and Don’ts

• Do take your pill at the exact same time every day to ensure maximum contraceptive efficacy.
• Do inform your doctor immediately if you develop new or worsening severe headaches, vision changes, or calf pain.
• Do not smoke while using combined hormonal contraceptives.
• Do not use herbal supplements containing St. John’s Wort while on oral contraception.

Frequently Asked Questions

References

• DrugBank Database – Nomegestrol Clinical and Pharmacological Profile
• European Medicines Agency (EMA) Summary of Product Characteristics for Zoely (Nomegestrol acetate / Estradiol)
• EMA Pharmacovigilance Risk Assessment Committee (PRAC) Safety Reviews on High-Dose Nomegestrol Acetate

Legal Disclaimer

The information provided is for educational purposes only and does not constitute medical advice. Always consult a qualified healthcare provider regarding medical conditions or treatment plans.